This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products.
Danaher (DHR) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
Danaher (DHR) possesses solid growth attributes, which could help it handily outperform the market.
Choose These 5 Low Leverage Stocks to Keep Your Portfolio Safe
by Aparajita Dutta
To protect one's portfolio from suffering huge losses, investors mostly choose stocks that bear low leverage. You may buy HZO, TITN, SPH, DHR and TD.
Danaher (DHR) Shares Gain 11% in 3 Months: What's Driving It?
by Zacks Equity Research
Danaher (DHR), with an 11% rise in shares in the past three months, gains from solid product offerings, the pandemic-induced demand and focus on innovation. Inorganic activities too have been aiding.
The Zacks Analyst Blog Highlights: Danaher Corp, The PNC Financial Services, Aon, Advanced Micro Devices and Enterprise Products Partners
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Danaher Corp, The PNC Financial Services, Aon, Advanced Micro Devices and Enterprise Products Partners
Top Research Reports for Danaher, PNC Financial, & Aon
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Danaher Corporation (DHR), The PNC Financial Services Group, Inc. (PNC) and Aon plc (AON).
HC2 Holdings (HCHC) Unit Buys Banker Steel, Enters Credit Agreement
by Zacks Equity Research
HC2 Holdings' (HCHC) unit DBM Global's buyout of Banker Steel is anticipated to boost its presence in the U.S. infrastructure market. Also, its credit arrangement will help lower cost of funds and improve liquidity.
Parker-Hannifin (PH) to Gain From Healthy Demand Amid Cost Woes
by Zacks Equity Research
Parker-Hannifin (PH) to gain from improving product demand and cost actions. The persistence of weakness in Aerospace Systems, and realignment and other expenses might hurt.
Should You Invest in the Invesco DWA Healthcare Momentum ETF (PTH)?
by Zacks Equity Research
Sector ETF report for PTH
Crane (CR) Beats Q1 Earnings and Sales Estimates, Ups View
by Zacks Equity Research
Crane's (CR) Q1 results improve year over year on the back of solid sales and margin performance. It raises projections for 2021, anticipating strengthening end-market businesses.
FSS vs. DHR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
FSS vs. DHR: Which Stock Is the Better Value Option?
General Electric (GE) Q1 Earnings Top Estimates, Revenues Lag
by Zacks Equity Research
General Electric's (GE) first-quarter 2021 earnings beat estimates and improve year over year as lower costs and expenses offset the decline in revenues. It maintains projections for 2021.
Danaher's (DHR) Q1 Earnings & Revenues Surpass Estimates
by Zacks Equity Research
Danaher's (DHR) first-quarter 2021 revenues increase 57.9% year over year on account of impressive performance across its segments.
eBay (EBAY) Gears Up for Q1 Earnings: What'S in the Cards?
by Zacks Equity Research
Performance of eBay'S (EBAY) core marketplace business is likely to have been impressive in Q1.
Danaher (DHR) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Danaher (DHR) delivered earnings and revenue surprises of 50.90% and 0.57%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Why Earnings Season Could Be Great for Danaher Corp (DHR)
by Zacks Equity Research
Danaher Corp (DHR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Honeywell (HON) to Report Q1 Earnings: Is a Beat in the Cards?
by Zacks Equity Research
Honeywell (HON) is likely to have benefited from strength in its operating segments. Soft commercial original equipment and aftermarket businesses and repositioning charges might have hurt its Q1 earnings.
Danaher (DHR) to Report Q1 Earnings: Is a Beat in the Cards?
by Zacks Equity Research
Danaher's (DHR) Q1 earnings are expected to have gained from strength across its business segments despite the coronavirus outbreak-led issues.
Danaher (DHR) Exhibits Bright Prospects, Headwinds Remain
by Zacks Equity Research
Danaher (DHR) benefits from strength across its businesses, acquisitions and shareholder-friendly policies. However, rising costs and expenses remain concerning.
The Zacks Analyst Blog Highlights: Abbott, Salesforce, BHP Group, Danaher and Zoom Video
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Abbott, Salesforce, BHP Group, Danaher and Zoom Video
Top Stock Reports for Abbott, salesforce & BHP
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories (ABT), salesforce.com (CRM), and BHP Group (BHP).
Danaher (DHR) Surges 3.4%: Is This an Indication of Further Gains?
by Zacks Equity Research
Danaher (DHR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Danaher (DHR) Q1 Revenue Projections Increase, Shares Gain
by Zacks Equity Research
Danaher (DHR) raises revenue projection for the first quarter of 2021 on strengthening Diagnostics and Life Sciences businesses.
Will Danaher (DHR) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Danaher (DHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
SSUMY vs. DHR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
SSUMY vs. DHR: Which Stock Is the Better Value Option?
Icahn Enterprises (IEP) Prices $455M Senior Notes Offering
by Zacks Equity Research
Icahn Enterprises (IEP) prices senior notes offering. It intends to use net proceeds for the redemption of other senior notes that are due to mature in 2022.